The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
Association of reduced intensity conditioning (RIC) allograft (alloHCT) as first transplant approach in relapsed/refractory grade 3(G-3) follicular lymphoma (FL) with improved outcomes in long-term survivors.
 
Evgeny Klyuchnikov
No Relationships to Disclose
 
Ulrike Bacher
No Relationships to Disclose
 
Nicolaus Kröger
No Relationships to Disclose
 
Parameswaran Hari
Stock and Other Ownership Interests - Pharmacyclics
Honoraria - Celgene; Millennium; Onyx; Sanofi
Consulting or Advisory Role - Celgene; Millennium; Onyx; Sanofi
Research Funding - Celgene (Inst); Millennium (Inst)
 
Kwang Woo Ahn
No Relationships to Disclose
 
David G. Maloney
No Relationships to Disclose
 
Sonali M. Smith
Honoraria - Celgene; Janssen Oncology
Consulting or Advisory Role - Celgene; Genentech/Roche; Gilead Sciences; immunogenix; onyx; Pharmacyclics; Seagen; Seagen; TG Therapeutics
Speakers' Bureau - Janssen Oncology; Spectrum Pharmaceuticals
 
Anna M. Sureda
No Relationships to Disclose
 
Jeanette Carreras
No Relationships to Disclose
 
Mehdi Hamadani
Honoraria - Celgene
Consulting or Advisory Role - Celerant; MedImmune
Research Funding - Takeda